ARTICLES BY THIS AUTHOR
- 2/16/2021
Slayback taps Dave Picard as chief commercial officer
Dave Picard, formerly senior vice president of global generic pharmaceuticals at AmerisourceBergen, is joining Slayback as chief commercial officer. - 2/16/2021
CVS Health's pandemic strategy pays off as Q4, full-year results beat expectations
CVS Health saw revenues increase 4% for the fourth quarter and 4.6% for the year ended Dec. 31, 2020. - 2/12/2021
APhA Foundation names new executive fellow, class of executive residents
Olivia Welter, the 2021-2022 Knowlton Center Executive Fellow in Association Management and Leadership, starts a year-long fellowship in June. - 2/11/2021
McKesson RxOwnership expands Pharmacy Ownership Workshop series
McKesson RxOwnership signed a new five-year commitment with the National Community Pharmacists Association to sponsor the Pharmacy Ownership Workshop series. - 2/11/2021
IQVIA’s Long offers view of pharmaceutical industry amid COVID pandemic
IQVIA's Doug Long weighed in on the pharmaceutical market amid COVID-19 during a DSN webinar held Thursday. - 2/12/2021
Sandoz to acquire GSK's antibiotics cephalosporin business
Sandoz is acquiring GSK’s cephalosporin antibiotics business, including three established brands, Zinnat, Zinacef and Fortum. - 2/12/2021
Akorn obtains FDA green light for loteprednol etabonate ophthalmic gel
Loteprednol etabonate ophthalmic gel 0.5% had a market value of approximately $35 million for the 12 months ended December 2020, according to IQVIA. - 2/11/2021
Glenmark gets FDA nod for generic Cleocin T Gel
The Cleocin T Gel had a market value of approximately $73.8 million for the 12 months ended December 2020, according to IQVIA. - 2/10/2021
APhA names Shannon Morrison CFO
Shannon Morrison, succeeds Joe Janela as CFO, who is retiring after 11 years at APhA. - 2/10/2021
Regeneron, Sanofi get FDA nod for new indication for Libtayo
Libtayo is now approved for both advanced cutaneous squamous cell and basal cell carcinomas.